Correlation of immune phenotype with IDH mutation in diffuse glioma

BACKGROUND: Tumor infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) are targets of immune checkpoint inhibitors. METHODS: Forty-three World Health Organization (WHO) grade II/III gliomas (39 IDH-mutant [mut], 4 IDH-wildtype [wt]) and 14 IDH-mut glioblastomas (GBM) were analyzed f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Berghoff, Anna Sophie, Kiesel, Barbara, Widhalm, Georg, Wilhelm, Dorothee, Rajky, Orsolya, Kurscheid, Sebastian, Kresl, Philip, Wöhrer, Adelheid, Marosi, Christine, Hegi, Monika E, Preusser, Matthias
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5737620/
https://ncbi.nlm.nih.gov/pubmed/28531337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars